Conmed (CNMD) Non-Current Deferred Tax Liability (2010 - 2026)

Conmed (CNMD) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $84.6 million in Q2 2026.

• Quarterly Non-Current Deferred Tax Liability rose 21.15% year-over-year to $84.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $84.6 million (up 21.15% YoY) and the FY2025 annual result came in at $79.5 million, down 55.11% from the prior year.
• Non-Current Deferred Tax Liability improved to $84.6 million in Q2 2026, from $81.4 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $177.2 million in Q4 2024 to a low of $63.2 million in Q1 2022.
• A 5-year average of $91.8 million and a median of $72.4 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 91.0% — and 2025, when it sank 55.11%.
• Tracing CNMD's Non-Current Deferred Tax Liability over 5 years: stood at $170.4 million in 2022, then slipped by 0.14% to $170.2 million in 2023, then grew by 4.11% to $177.2 million in 2024, then slumped by 55.11% to $79.5 million in 2025, then increased by 6.35% to $84.6 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $84.6 million (Q2 2026), $81.4 million (Q1 2026), and $79.5 million (Q4 2025), per Business Quant data.